OTC

Strength

325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1

NDC

83324010620

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

8/7/2024

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

-5.1%

3M

+1.2%

6M

+4.3%

1Y

-5.1%

3Y

N/A

5Y

N/A

All

+1.9%